Jennifer Knight, MD, MS, FACLP

Publications

• The impact of beta-blocker use at the time of hematopoietic cell transplantation on the development of acute and chronic graft-versus-host disease.

  (Patel A, Subramanian Guru Murthy G, Hamadani M, Szabo A, Knight JM.) Hematol Oncol Stem Cell Ther. 2021 Nov 05 PMID: 34780786 SCOPUS ID: 2-s2.0-85119520781 11/16/2021

• The biology of stress in cancer: Applying the biobehavioral framework to adolescent and young adult oncology research.

  (Taylor MR, Knight JM, Rosenberg AR.) Brain Behav Immun Health. 2021 Nov;17:100321 PMID: 34589815 PMCID: PMC8474169 10/01/2021

• Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy.

  (Kelly DL, Syrjala K, Taylor M, Rentscher KE, Hashmi S, Wood WA, Jim H, Barata A, Flynn KE, Burns LJ, Shaw BE, Petersdorf E, Yero AC, Emmrich AD, Morris KE, Costanzo ES, Knight JM.) Transplant Cell Ther. 2021 09;27(9):747-757 PMID: 34139388 PMCID: PMC8428782 SCOPUS ID: 2-s2.0-85110419978 06/18/2021

• Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies.

  (Alabdaljabar MS, Muhsen IN, Knight JM, Syrjala KL, Hashmi SK.) Blood Rev. 2021 07;48:100783 PMID: 33342584 PMCID: PMC8166938 SCOPUS ID: 2-s2.0-85099517313 12/22/2020

• Reducing distress and depression in cancer patients during survivorship.

  (Molinaro J, Banerjee A, Lyndon S, Slocum S, Danhieux-Poole C, Restivo-Pritzl C, Uselmann AM, Wallace L, Knight JM.) Psychooncology. 2021 06;30(6):962-969 PMID: 33797112 SCOPUS ID: 2-s2.0-85104016693 04/03/2021

• Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.

  (Bona K, Brazauskas R, He N, Lehmann L, Abdel-Azim H, Ahmed IA, Al-Homsi AS, Aljurf M, Arnold SD, Badawy SM, Battiwalla M, Beattie S, Bhatt NS, Dalal J, Dandoy CE, Diaz MA, Frangoul HA, Freytes CO, Ganguly S, George B, Gomez-Almaguer D, Hahn T, Kamble RT, Knight JM, LeMaistre CF, Law J, Lazarus HM, Majhail NS, Olsson RF, Preussler J, Savani BN, Schears R, Seo S, Sharma A, Srivastava A, Steinberg A, Szwajcer D, Wirk B, Yoshimi A, Khera N, Wood WA, Hashmi S, Duncan CN, Saber W.) Blood. 2021 01 28;137(4):556-568 PMID: 33104215 PMCID: PMC7845011 SCOPUS ID: 2-s2.0-85099936348 10/27/2020

• The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill.

  (Knight JM, Costanzo ES, Singh S, Yin Z, Szabo A, Pawar DS, Hillard CJ, Rizzo JD, D'Souza A, Pasquini M, Coe CL, Irwin MR, Raison CL, Drobyski WR.) Transl Psychiatry. 2021 01 18;11(1):58 PMID: 33462203 PMCID: PMC7812704 SCOPUS ID: 2-s2.0-85100097244 01/20/2021

• Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies

  (Alabdaljabar MS, Muhsen IN, Knight JM, Syrjala KL, Hashmi SK.) Blood Reviews. July 2021;48 SCOPUS ID: 2-s2.0-85099517313 07/01/2021

• Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.

  (Pisano M, Cheng Y, Sun F, Dhakal B, D'Souza A, Chhabra S, Knight JM, Rao S, Zhan F, Hari P, Janz S.) Front Immunol. 2021;12:667054 PMID: 34149703 PMCID: PMC8206561 SCOPUS ID: 2-s2.0-85108140164 06/22/2021

• Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

  (Tay J, Beattie S, Bredeson C, Brazauskas R, He N, Ahmed IA, Aljurf M, Askar M, Atsuta Y, Badawy S, Barata A, Beitinjaneh AM, Bhatt NS, Buchbinder D, Cerny J, Ciurea S, D'Souza A, Dalal J, Farhadfar N, Freytes CO, Ganguly S, Gergis U, Gerull S, Lazarus HM, Hahn T, Hong S, Inamoto Y, Khera N, Kindwall-Keller T, Kamble RT, Knight JM, Koleva YN, Kumar A, Kwok J, Murthy HS, Olsson RF, Angel Diaz-Perez M, Rizzieri D, Seo S, Chhabra S, Schoemans H, Schouten HC, Steinberg A, Sullivan KM, Szer J, Szwajcer D, Ulrickson ML, Verdonck LF, Wirk B, Wood WA, Yared JA, Saber W.) Curr Oncol. 2020 12;27(6):e596-e606 PMID: 33380875 PMCID: PMC7755447 SCOPUS ID: 2-s2.0-85099179182 01/01/2021

• The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.

  (Arnold SD, Brazauskas R, He N, Li Y, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Hashmi S, Parsons S, Wood WA, Steinberg A, Freytes CO, Dandoy CE, Marks DI, Lazarus HM, Abdel-Azim H, Bitan M, Diaz MA, Olsson RF, Gergis U, Seber A, Wirk B, LeMaistre CF, Ustun C, Duncan C, Rizzieri D, Szwajcer D, Fagioli F, Frangoul H, Knight JM, Kamble RT, Mehta P, Schears R, Satwani P, Pulsipher MA, Aplenc R, Saber W.) Biol Blood Marrow Transplant. 2020 09;26(9):1747-1756 PMID: 32464284 PMCID: PMC7518194 SCOPUS ID: 2-s2.0-85087396573 05/29/2020

• Capsule Commentary on Zheng et al., The Role of Spirituality in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Mixed Studies Review

  (Murthy GSG, Jerkins J, Knight J.) Journal of General Internal Medicine. 1 July 2020;35(7):2253 SCOPUS ID: 2-s2.0-85085524223 07/01/2020